AEVIS VICTORIA SA Logo

AEVIS VICTORIA SA

ISIN

CH0478634105

Ticker

AEVS

Sector

Health Care

Sub-Industry

Health Care Facilities

Country

Switzerland

Year Founded

2006

About AEVIS VICTORIA SA

Company Description

AEVIS VICTORIA is an investment company founded in 2006 and listed under the Swiss Reporting Standard of the SIX Swiss Exchange. In keeping with its mission, investing for a better life, the company pursues an investment strategy that focuses on three areas with high added value and strong growth potential: healthcare, lifestyle and infrastructure. AEVIS VICTORIA′s main shareholdings are Swiss Medical Network SA (90%, directly and indirectly), the only Swiss private network of hospitals present in the country’s three main language regions, Victoria-Jungfrau SA, a luxury hotel group managing ten luxury hotels in Switzerland and abroad, Infracore SA (30%, directly and indirectly), a real estate company dedicated to healthcare-related infrastructure, Swiss Hotel Properties SA, a hospitality real estate division and NESCENS SA, a brand dedicated to better aging.

Served Area

Switzerland

Headquarters

Rue Georges-Jordil 4
1700, Fribourg
Switzerland

Insider Trades

Date Trading entity / Person Association Trade type Volume
17.06.2024 None Executive member Sell CHF 6,100,000.00
17.06.2024 None Non-Executive member Buy CHF 6,100,000.00
30.05.2024 None Executive member Buy CHF 14,946.60
26.04.2024 None Non-Executive member Buy CHF 3,960,000.00
26.04.2024 None Executive member Sell CHF 2,376,000.00
26.04.2024 None Executive member Sell CHF 1,584,000.00
03.04.2024 None Non-Executive member Buy CHF 52,502.10
03.04.2024 None Non-Executive member Buy CHF 39,992.40
03.04.2024 None Non-Executive member Buy CHF 25,003.30
03.04.2024 None Non-Executive member Buy CHF 10,593.80

Capital Markets Information

ISIN

CH0478634105

LEI

8945007IU37NXIYRG176

Listed Stock Exchange

SIX Swiss Exchange

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.